Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

MPLTMapLight Therapeutics, Inc.

Nasdaq · CIK 0001770069
Filer category<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts170

Identity from submissions API

NameMapLight Therapeutics, Inc.
CIK0001770069
TickersMPLT
ExchangesNasdaq
Entity typeoperating
Category<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN832163243
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone617-984-6300
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Alvarado Therapeutics, Inc. (2019-03-08T05:00:00.000Z → 2019-03-22T04:00:00.000Z)
Business address
800 CHESAPEAKE DRIVE
REDWOOD CITY
CA
94063
CA
Mailing address
800 CHESAPEAKE DRIVE
REDWOOD CITY
CA
94063
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

217 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-17 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003560 333-298837 261567920 33 1843
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001897612-26-000762 005-95298 261556537 34 7778
2026-11-16 8-K 8-K 1.01,9.01 0001193125-26-462385 001-42914 261556089 34 143782 1 1
2026-11-16 S-3 S-3 0001193125-26-462295 333-300071 261555826 33 1535746 1 1
2026-11-16 POS AM POS AM 0001193125-26-462287 333-298837 261555814 33 262280
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-462143 005-95298 261555484 34 8696
2026-11-16 10-Q 10-Q 0001193125-26-462097 001-42914 261555428 34 10630969 1 1
2026-11-16 8-K 8-K 2.02,7.01,9.01 0001193125-26-462061 001-42914 261555391 34 14425351 1 1
2026-10-16 4 xslF345X06/form4-10162026_051014.xml 0002021238-26-000014 5375
2026-10-16 4 xslF345X06/form4-10162026_051011.xml 0001709954-26-000014 5894
2026-10-16 4 xslF345X06/form4-10162026_051008.xml 0001728746-26-000018 5911
2026-10-16 4 xslF345X06/form4-10162026_051005.xml 0001789970-26-000018 5893
2026-10-16 4 xslF345X06/form4-10162026_051003.xml 0002021233-26-000016 5900
2026-10-16 4 xslF345X06/form4-10162026_051001.xml 0001658918-26-000018 6844
2026-10-15 144 xsl144X01/primary_doc.xml 0001974158-26-000108 001-42914 261464030 33 8944
2026-10-15 144 xsl144X01/primary_doc.xml 0001974158-26-000107 001-42914 261463920 33 11281
2026-10-15 144 xsl144X01/primary_doc.xml 0001974158-26-000106 001-42914 261463830 33 8973
2026-10-15 144 xsl144X01/primary_doc.xml 0001974158-26-000105 001-42914 261463784 33 8449
2026-10-15 144 xsl144X01/primary_doc.xml 0001974158-26-000104 001-42914 261463697 33 8959
2026-10-15 144 xsl144X01/primary_doc.xml 0001950047-26-010262 001-42914 261463463 33 4849
2026-10-15 144 xsl144X01/primary_doc.xml 0001193125-26-422882 001-42914 261463167 33 8886
2026-09-23 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003044 333-298837 261402048 33 1830
2026-09-23 424B3 424B3 0001193125-26-399452 333-298837 261401252 33 951760
2026-09-18 S-1/A S-1/A 0001193125-26-395559 333-298837 261391079 33 1041149
2026-09-18 4 xslF345X06/form4-09182026_040901.xml 0001789970-26-000016 5544
2026-09-16 144 xsl144X01/primary_doc.xml 0001974158-26-000102 001-42914 261383969 33 6563
2026-09-09 S-1 S-1 0001193125-26-386648 333-298837 261369022 33 1200779 1 1
2026-08-20 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001012975-26-000807 005-95298 261299897 34 81989
2026-08-19 4 xslF345X06/form4-08192026_060813.xml 0002021238-26-000012 7818
2026-08-19 4 xslF345X06/form4-08192026_060811.xml 0001709954-26-000012 11933
2026-08-19 4 xslF345X06/form4-08192026_060808.xml 0001728746-26-000016 7831
2026-08-19 4 xslF345X06/form4-08192026_060806.xml 0001789970-26-000014 7814
2026-08-19 4 xslF345X06/form4-08192026_060804.xml 0002021233-26-000014 7821
2026-08-19 4 xslF345X06/form4-08192026_060801.xml 0001658918-26-000016 8765
2026-08-18 4 xslF345X06/form4-08182026_100832.xml 0001900201-26-000005 7913
2026-08-18 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001104659-26-098444 005-95298 261292445 34 17947
2026-08-13 10-Q 10-Q 0001193125-26-349554 001-42914 261274710 34 9656438 1 1
2026-08-13 8-K 8-K 1.01,2.02,3.02,7.01,9.01 0001193125-26-349490 001-42914 261274561 34 4568275 1 1
2026-08-04 4 xslF345X06/form4-08052026_120851.xml 0001728746-26-000014 5579
2026-08-03 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001104659-26-089960 005-95298 261235116 34 18147
2026-08-03 144 xsl144X01/primary_doc.xml 0001974158-26-000093 001-42914 261232674 33 8896
2026-07-31 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001388325-26-000034 005-95298 261225699 34 31447
2026-07-30 144 xsl144X01/primary_doc.xml 0001388325-26-000032 001-42914 261225124 33 6189
2026-07-30 4 xslF345X06/form4-07302026_100713.xml 0001900201-26-000003 10768
2026-07-28 4 xslF345X06/form4-07292026_010736.xml 0001696923-26-000007 6405
2026-07-27 8-K 8-K 7.01,8.01,9.01 0001193125-26-316820 001-42914 261202803 34 12400645 1 1
2026-07-20 4 xslF345X06/form4-07202026_060704.xml 0001709954-26-000010 18579
2026-07-20 4 xslF345X06/form4-07202026_060701.xml 0002021238-26-000010 18063
2026-07-17 4 xslF345X06/form4-07182026_010744.xml 0001658918-26-000014 18079
2026-07-17 4 xslF345X06/form4-07182026_010728.xml 0001728746-26-000012 17135
2026-07-17 4 xslF345X06/form4-07182026_010724.xml 0001789970-26-000012 17100
2026-07-17 4 xslF345X06/form4-07182026_010714.xml 0002021233-26-000012 21362
2026-07-17 144 xsl144X01/primary_doc.xml 0001950047-26-007189 001-42914 261183996 33 6274
2026-07-17 144 xsl144X01/primary_doc.xml 0001950047-26-007188 001-42914 261183991 33 6992
2026-07-15 144/A xsl144X01/primary_doc.xml 0001193125-26-305203 001-42914 261178535 33 5818
2026-07-15 144 xsl144X01/primary_doc.xml 0001193125-26-305149 001-42914 261178422 33 6369
2026-07-15 144 xsl144X01/primary_doc.xml 0001193125-26-305146 001-42914 261178419 33 5736
2026-07-15 144 xsl144X01/primary_doc.xml 0001974158-26-000081 001-42914 261177851 33 9960
2026-07-15 144 xsl144X01/primary_doc.xml 0001950047-26-007105 001-42914 261177633 33 4849
2026-07-15 144 xsl144X01/primary_doc.xml 0001974158-26-000080 001-42914 261177576 33 12059
2026-07-15 144 xsl144X01/primary_doc.xml 0001974158-26-000079 001-42914 261177512 33 8438
2026-07-15 144 xsl144X01/primary_doc.xml 0001974158-26-000078 001-42914 261177406 33 9736
2026-06-25 4 xslF345X06/form4-06252026_100620.xml 0001696923-26-000005 8137
2026-06-25 4 xslF345X06/form4-06252026_100631.xml 0001435618-26-000011 8033
2026-06-25 4 xslF345X06/form4-06252026_090607.xml 0001998937-26-000004 9043
2026-06-25 4 xslF345X06/form4-06252026_090604.xml 0002089511-26-000002 8171
2026-06-25 4 xslF345X06/form4-06252026_090639.xml 0001470798-26-000004 8136
2026-06-25 4 xslF345X06/form4-06252026_090603.xml 0001826519-26-000002 8131
2026-06-25 3 xslF345X06/form3-06252026_090615.xml 0001696923-26-000003 8674
2026-06-25 3 xslF345X06/form3-06252026_090600.xml 0001435618-26-000009 8580
2026-06-24 8-K 8-K 5.07 0001193125-26-280243 001-42914 261112976 34 145286 1 1
2026-06-22 8-K 8-K 7.01,8.01,9.01 0001193125-26-276691 001-42914 261104884 34 2738918 1 1
2026-06-18 8-K 8-K 5.02 0001193125-26-276065 001-42914 261103844 34 138810 1 1
2026-05-18 4 xslF345X06/form4-05192026_010517.xml 0001658918-26-000012 7623
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001897612-26-000505 005-95298 26983424 34 7704
2026-05-14 10-Q 10-Q 0001193125-26-224129 001-42914 26979446 34 8548356 1 1
2026-05-14 8-K 8-K 2.02,7.01,9.01 0001193125-26-224067 001-42914 26979139 34 16390006 1 1
2026-05-11 4 xslF345X06/form4-05112026_090506.xml 0001789970-26-000010 11665
2026-05-11 4 xslF345X06/form4-05112026_090504.xml 0001658918-26-000010 22853
2026-05-11 4 xslF345X06/form4-05112026_090503.xml 0002021233-26-000010 7606
2026-05-11 4 xslF345X06/form4-05112026_090501.xml 0001728746-26-000010 5576
2026-05-06 4 xslF345X06/form4-05062026_080509.xml 0002021256-26-000008 19842
2026-05-06 4 xslF345X06/form4-05062026_080507.xml 0002021233-26-000008 19849
2026-05-06 4 xslF345X06/form4-05062026_080505.xml 0001728746-26-000008 19861
2026-05-06 4 xslF345X06/form4-05062026_080503.xml 0001789970-26-000008 11664
2026-05-06 4 xslF345X06/form4-05062026_080501.xml 0001658918-26-000008 20802
2026-05-04 144 xsl144X01/primary_doc.xml 0001974158-26-000067 001-42914 26939403 33 6017
2026-05-04 144 xsl144X01/primary_doc.xml 0001974158-26-000066 001-42914 26939291 33 5980
2026-05-04 144 xsl144X01/primary_doc.xml 0001974158-26-000065 001-42914 26939226 33 5959
2026-05-04 144 xsl144X01/primary_doc.xml 0001974158-26-000064 001-42914 26939196 33 5989
2026-05-04 144 xsl144X01/primary_doc.xml 0001974158-26-000063 001-42914 26939164 33 5980
2026-04-29 4 xslF345X06/form4-04292026_040431.xml 0001709954-26-000008 13716
2026-04-29 4 xslF345X06/form4-04292026_040429.xml 0002021238-26-000008 9645
2026-04-29 8-K 8-K 5.02 0001193125-26-191566 001-42914 26916134 34 136533 1 1
2026-04-29 ARS ARS 0001193125-26-191542 001-42914 26916045 34 1459505
2026-04-29 DEFA14A DEFA14A 0001193125-26-191518 001-42914 26915895 34 493532
2026-04-29 DEF 14A DEF 14A 0001193125-26-191449 001-42914 26915649 34 1604674 1 1
2026-04-27 144 xsl144X01/primary_doc.xml 0001950047-26-003784 001-42914 26901545 33 5707
2026-04-27 144 xsl144X01/primary_doc.xml 0001950047-26-003775 001-42914 26901513 33 6306
2026-04-17 4 xslF345X06/form4-04172026_040415.xml 0002021238-26-000006 5606
2026-04-17 4 xslF345X06/form4-04172026_040413.xml 0001709954-26-000006 5761
2026-04-17 4 xslF345X06/form4-04172026_040411.xml 0001789970-26-000006 9259
2026-04-17 4 xslF345X06/form4-04172026_040410.xml 0002021256-26-000006 9110
2026-04-17 4 xslF345X06/form4-04172026_040408.xml 0001728746-26-000006 9296
2026-04-17 4 xslF345X06/form4-04172026_040406.xml 0002021233-26-000006 9284
2026-04-17 4 xslF345X06/form4-04172026_040404.xml 0001658918-26-000006 10066
2026-04-17 4 xslF345X06/form4-04172026_040402.xml 0002021198-26-000013 6474
2026-04-15 144 xsl144X01/primary_doc.xml 0001193125-26-157260 001-42914 26864956 33 4579
2026-04-15 144 xsl144X01/primary_doc.xml 0001193125-26-157249 001-42914 26864918 33 4579
2026-04-15 144/A xsl144X01/primary_doc.xml 0001974158-26-000053 001-42914 26864735 33 5614
2026-04-15 144 xsl144X01/primary_doc.xml 0001950047-26-003510 001-42914 26864692 33 12503
2026-04-15 144/A xsl144X01/primary_doc.xml 0001974158-26-000052 001-42914 26864661 33 5626
2026-04-15 144/A xsl144X01/primary_doc.xml 0001974158-26-000051 001-42914 26864581 33 4450
2026-04-15 144/A xsl144X01/primary_doc.xml 0001974158-26-000050 001-42914 26864531 33 5614
2026-04-15 144 xsl144X01/primary_doc.xml 0001974158-26-000049 001-42914 26864470 33 5498
2026-04-15 144 xsl144X01/primary_doc.xml 0001974158-26-000048 001-42914 26864361 33 4246
2026-04-15 144 xsl144X01/primary_doc.xml 0001974158-26-000047 001-42914 26864297 33 5423
2026-04-15 144 xsl144X01/primary_doc.xml 0001974158-26-000046 001-42914 26864269 33 5412
2026-04-15 144 xsl144X01/primary_doc.xml 0001974158-26-000044 001-42914 26864205 33 5411
2026-03-26 S-8 S-8 0001193125-26-125105 333-294620 26794379 33 190291 1 1
2026-03-26 10-K 10-K 0001193125-26-125072 001-42914 26794319 34 20385607 1 1
2026-03-26 8-K 8-K 2.02,7.01,9.01 0001193125-26-125062 001-42914 26794308 34 16367143 1 1
2026-02-24 4 xslF345X05/form4-02242026_110209.xml 0002021198-26-000011 13069
2026-02-24 144 xsl144X01/primary_doc.xml 0001950047-26-001737 001-42914 26672295 33 11753
2026-02-23 144 xsl144X01/primary_doc.xml 0001950047-26-001664 001-42914 26665789 33 11060
2026-02-20 4 xslF345X05/form4-02202026_060201.xml 0001470798-26-000002 9200
2026-02-20 144 xsl144X01/primary_doc.xml 0001950047-26-001564 001-42914 26660152 33 10361
2026-02-18 4 xslF345X05/form4-02192026_120233.xml 0002021198-26-000009 6975
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001897612-26-000296 005-95298 26637772 34 7457
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-053187 005-95298 26636698 34 8557
2026-02-13 144 xsl144X01/primary_doc.xml 0001950047-26-001246 001-42914 26632774 33 9666
2026-02-12 4 xslF345X05/form4-02122026_050203.xml 0001998937-26-000002 6120
2026-02-12 4 xslF345X05/form4-02122026_050201.xml 0002021198-26-000007 8492
2026-02-11 144 xsl144X01/primary_doc.xml 0001950047-26-001147 001-42914 26620868 33 8966
2026-02-10 144 xsl144X01/primary_doc.xml 0001950047-26-001098 001-42914 26616312 33 8273
2026-02-09 4 xslF345X05/form4-02092026_050212.xml 0001709954-26-000004 7675
2026-02-09 4 xslF345X05/form4-02092026_050210.xml 0002021256-26-000004 7682
2026-02-09 4 xslF345X05/form4-02092026_050209.xml 0001728746-26-000004 7699
2026-02-09 4 xslF345X05/form4-02092026_050207.xml 0002021238-26-000004 7686
2026-02-09 4 xslF345X05/form4-02092026_050205.xml 0001789970-26-000004 7664
2026-02-09 4 xslF345X05/form4-02092026_050203.xml 0002021233-26-000004 7689
2026-02-09 4 xslF345X05/form4-02092026_050201.xml 0001658918-26-000004 8633
2026-02-04 4 xslF345X05/form4-02052026_020204.xml 0002021198-26-000005 8490
2026-02-03 144 xsl144X01/primary_doc.xml 0001950047-26-000881 001-42914 26593090 33 7573
2026-02-02 144 xsl144X01/primary_doc.xml 0001950047-26-000840 001-42914 26588450 33 6886
2026-01-30 4 xslF345X05/form4-01312026_010139.xml 0002021198-26-000003 13070
2026-01-30 144 xsl144X01/primary_doc.xml 0001950047-26-000766 001-42914 26583632 33 6189
2026-01-29 4 xslF345X05/form4-01292026_040112.xml 0002021256-26-000002 5433
2026-01-29 4 xslF345X05/form4-01292026_040111.xml 0001728746-26-000002 5449
2026-01-29 4 xslF345X05/form4-01292026_040109.xml 0002021238-26-000002 5436
2026-01-29 4 xslF345X05/form4-01292026_040103.xml 0001709954-26-000002 5425
2026-01-29 4 xslF345X05/form4-01292026_040107.xml 0001658918-26-000002 6383
2026-01-29 4 xslF345X05/form4-01292026_040101.xml 0002021233-26-000002 5438
2026-01-29 4 xslF345X05/form4-01292026_040105.xml 0001789970-26-000002 5414
2026-01-29 144 xsl144X01/primary_doc.xml 0001950047-26-000748 001-42914 26577928 33 5493
2026-01-28 144 xsl144X01/primary_doc.xml 0001950047-26-000728 001-42914 26572723 33 4794
2026-01-09 8-K 8-K 2.02,7.01,9.01 0001193125-26-008267 001-42914 26521342 34 16188680 1 1
2025-12-04 10-Q 10-Q 0001193125-25-307453 001-42914 251548260 34 10755724 1 1
2025-12-04 8-K 8-K 2.02,7.01,9.01 0001193125-25-307450 001-42914 251548252 34 15091932 1 1
2025-11-20 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-114697 005-95298 251504350 34 25373
2025-11-18 3/A xslF345X02/form3a-11192025_021158.xml 0001470798-25-000008 3471
2025-11-04 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001388325-25-000021 005-95298 251449456 34 42669
2025-10-30 4 xslF345X05/form4-10302025_081039.xml 0001388325-25-000018 11256
2025-10-29 4 xslF345X05/form4-10292025_081047.xml 0001900201-25-000008 21672
2025-10-29 8-K 8-K 3.02,5.03,8.01,9.01 0001193125-25-255041 001-42914 251427296 34 434368 1 1
2025-10-28 4 xslF345X05/form4-10282025_041020.xml 0001998937-25-000006 7631
2025-10-28 4 xslF345X05/form4-10282025_041018.xml 0001826519-25-000008 7665
2025-10-28 4 xslF345X05/form4-10282025_041016.xml 0001789970-25-000008 7664
2025-10-28 4 xslF345X05/form4-10282025_041014.xml 0001709954-25-000007 7675
2025-10-28 4 xslF345X05/form4-10282025_041012.xml 0002021238-25-000006 7686
2025-10-28 4 xslF345X05/form4-10282025_041010.xml 0001728746-25-000007 7699
2025-10-28 4 xslF345X05/form4-10282025_041009.xml 0002021256-25-000006 7682
2025-10-28 4 xslF345X05/form4-10282025_041007.xml 0002021233-25-000007 7688
2025-10-28 4 xslF345X05/form4-10282025_041005.xml 0002021198-25-000006 11827
2025-10-28 4 xslF345X05/form4-10282025_041001.xml 0001658918-25-000008 12465
2025-10-27 3 xslF345X02/form3-10272025_091011.xml 0001900201-25-000006 12383
2025-10-27 3 xslF345X02/form3-10272025_081056.xml 0001388325-25-000015 6091
2025-10-27 3 xslF345X02/form3-10272025_081021.xml 0002023265-25-000006 8468
2025-10-27 3 xslF345X02/form3-10272025_081013.xml 0001470798-25-000005 8495
2025-10-27 3 xslF345X02/form3-10272025_081034.xml 0002089511-25-000003 8532
2025-10-27 3 xslF345X02/form3-10272025_081026.xml 0001789970-25-000006 11679
2025-10-27 3 xslF345X02/form3-10272025_081046.xml 0002021238-25-000004 15106
2025-10-27 3 xslF345X02/form3-10272025_081019.xml 0002021233-25-000005 12889
2025-10-27 3 xslF345X02/form3-10272025_081052.xml 0001998937-25-000004 11663
2025-10-27 3 xslF345X02/form3-10272025_081030.xml 0001728746-25-000005 14345
2025-10-27 3 xslF345X02/form3-10272025_081031.xml 0002021256-25-000004 9847
2025-10-27 3 xslF345X02/form3-10272025_081049.xml 0001709954-25-000005 13982
2025-10-27 3 xslF345X02/form3-10272025_081036.xml 0001826519-25-000006 9885
2025-10-27 3 xslF345X02/form3-10272025_081050.xml 0001658918-25-000006 16694
2025-10-27 3 xslF345X02/form3-10272025_081019.xml 0002021198-25-000004 15229
2025-10-27 424B3 424B3 0001193125-25-251611 333-290400 251420078 33 5325110
2025-10-27 S-8 S-8 0001193125-25-250723 333-291087 251417504 33 237618 1 1
2025-10-27 FWP FWP 0001193125-25-250609 333-290400 251417325 34 13344
2025-10-24 CERT MPLT_8A_Cert_1770069.pdf 0001354457-25-001060 001-42914 251416944 34 594429
2025-10-24 8-A12B 8-A12B 0001193125-25-249941 001-42914 251416105 34 14883
2025-10-06 FWP FWP 0001193125-25-232052 333-290400 251377545 34 12222
2025-10-06 S-1/A S-1/A 0001193125-25-231829 333-290400 251376847 33 6155571 1 1
2025-09-19 S-1 S-1 0001193125-25-209084 333-290400 251326956 33 6625615 1 1
2025-08-22 DRSLTR filename1.htm 0000950123-25-008549 34394
2025-08-22 DRS/A filename1.htm 0000950123-25-008548 377-07130 251246016 33 5546504
2025-08-12 UPLOAD filename1.pdf 0000000000-25-008433 377-07130 46604
2025-07-30 DRS/A filename1.htm 0000950123-25-006751 377-07130 251163594 33 5798176
2025-07-28 D xslFormDX01/primary_doc.xml 06b 0001231919-25-000129 021-552922 251154751 33 16142
2024-05-10 DRSLTR filename1.htm 0000950123-24-004429 21034
2024-05-10 DRS/A filename1.htm 0000950123-24-004426 377-07130 24936115 33 5505708
2024-04-24 UPLOAD filename1.pdf 0000000000-24-004589 377-07130 45770
2024-04-12 DRSLTR filename1.htm 0000950123-24-003283 46168
2024-04-12 DRS/A filename1.htm 0000950123-24-003282 377-07130 24842176 33 5232066
2024-04-04 UPLOAD filename1.pdf 0000000000-24-003654 377-07130 58033
2024-03-08 DRS filename1.htm 0000950123-24-002827 377-07130 24735629 33 5045009
2023-11-03 D/A xslFormDX01/primary_doc.xml 06b 0001231919-23-000070 021-487390 231375754 33 15382
2023-07-19 D xslFormDX01/primary_doc.xml 06b 0001231919-23-000046 021-487390 231097612 33 14315
2022-11-10 D xslFormDX01/primary_doc.xml 06b 0001231919-22-000065 021-464468 221376213 33 11891
2021-03-10 D xslFormDX01/primary_doc.xml 06b 0001770069-21-000001 021-391790 21730371 33 11126
2019-09-04 D xslFormDX01/primary_doc.xml 06b 0001770069-19-000006 021-347993 191074461 33 10280
2019-03-22 D/A xslFormDX01/primary_doc.xml 06b 0001770069-19-000003 021-334440 19698385 33 10330
2019-03-08 D xslFormDX01/primary_doc.xml 06b 0001770069-19-000002 021-334440 19669966 33 9588

Latest XBRL company facts

One latest value per concept from companyfacts (170 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 42.44M 2026-03-19 2025 FY 10-K 2026-03-26 0001193125-26-125072
dei EntityPublicFloat Entity Public Float USD 0 2025-06-30 2025 FY 10-K 2026-03-26 0001193125-26-125072
ffd NetFeeAmt NetFeeAmt USD 34,800 2026-11-16 S-3 2026-11-16 0001193125-26-462295
ffd TtlFeeAmt TtlFeeAmt USD 34,800 2026-11-16 S-3 2026-11-16 0001193125-26-462295
ffd TtlOfferingAmt TtlOfferingAmt USD 400.00M 2026-11-16 S-3 2026-11-16 0001193125-26-462295
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-11-16 S-3 2026-11-16 0001193125-26-462295
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-11-16 S-3 2026-11-16 0001193125-26-462295
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 2.96M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 1.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 26.76M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 728,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 2.64M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -3.01M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 981.77M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD 7.50M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 10.26M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 28.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 8.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap Assets Assets USD 477.18M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap AssetsCurrent Assets, Current USD 294.60M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 3.01M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 410.85M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 407.85M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 55.57M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 453.10M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 56.64M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 9.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 18.44M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 55.67M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 55.67M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap CommonStockValue Common Stock, Value, Issued USD 6,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -175.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 507.66M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 403.80M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap DebtSecuritiesUnrealizedGainLoss Debt Securities, Unrealized Gain (Loss) USD 3.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 0 2025-12-31 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 89,487 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 21,107 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 96.60M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 13.10M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 3,320 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 13,473 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 6,720 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 89,487 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 800,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 0.04 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap Depreciation Depreciation USD 444,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap DividendsCommonStockCash Dividends, Common Stock, Cash USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap DividendsPreferredStock Dividends, Preferred Stock USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -3.6 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -3.6 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.244 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.01 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.033 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 7.42M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 41.80M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap EquityMethodInvestmentRealizedGainLossOnDisposal Equity Method Investment, Realized Gain (Loss) on Disposal USD -986,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -4,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 32.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 39.36M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -33.84M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 189,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -333,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 5.37M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -343,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 5.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -737,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -9.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 7.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap LeaseCost Lease, Cost USD 1.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 1.83M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.02M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 1.16M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 0 2026-06-30 2026 Q2 10-Q 2026-08-13 0001193125-26-349554
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 140,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 334,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 338,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 144,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap Liabilities Liabilities USD 31.41M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 477.18M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap LiabilitiesCurrent Liabilities, Current USD 30.90M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 5.14M 2025-09-30 2025 Q3 10-Q 2025-12-04 0001193125-25-307453
us-gaap LongTermInvestments Long-term Investments USD 179.33M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 143.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -2.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -131.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -172.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 7.93M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap NumberOfReportableSegments Number of Reportable Segments Segments 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap OperatingExpenses Operating Expenses USD 183.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -183.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap OperatingLeaseCost Operating Lease, Cost USD 928,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 1.69M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.18M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 510,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 1.45M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.095 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 750,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 14,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -2.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 3.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 7.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 209.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 58,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap PreferredStockDividendRatePercentage Preferred Stock, Dividend Rate, Percentage pure 0.08 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 10.52M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 1.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 85.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 207.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 124,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 3.73M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 722,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 151.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap RestrictedCash Restricted Cash USD 200,000 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 1.07M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -533.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 1.49M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap SegmentReportingOtherItemAmount SegmentReportingOtherItemAmount USD -10.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 28.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 4.22M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 877,850 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 5.38 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 233,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 15,359 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001193125-26-224129
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 16.7 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001193125-26-224129
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 240,417 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 13.76 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 13.45 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 4.22M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 4.81M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 14.95 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 300,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 8.97 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 16.83 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 17.34 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap ShortTermInvestments Short-term Investments USD 228.51M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 445.77M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.06 2025-10-01 2025-10-31 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 13,880 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 507.66M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 813,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 269.09M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 496,000 2025-04-01 2025-06-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 31,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 39.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-125072
us-gaap VariableLeaseCost Variable Lease, Cost USD 462,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 47.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 47.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462097

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →